Nemolizumab monotherapy may be an effective treatment for reducing pruritus and disease severity in adults with moderate to severe prurigo nodularis.

Experts shared diagnosis and management strategies for chronic pruritus at the Dermatology Days of Paris 2024 conference.

Mind-body therapies like meditation, psychotherapy, and deep breathing may help reduce stress levels, potentially reducing ...

Patients with chronic spontaneous urticaria experienced substantial reductions in hives and itch with briquilimab through 16 ...

“Taking precautions is about preserving hearing health for the long term,” Jenn Schumacher, an audiologist at ReSound, told ...

Titan Pharmaceuticals (NASDAQ:TTNP – Get Free Report) announced its earnings results on Friday. The specialty pharmaceutical ...

That uncomfortable urge to scratch your palms might be more than just an annoyance. While some dismiss itchy palms as merely ...

A woman with a known nut allergy had a severe allergic reaction after sex, even though her partner bathed and brushed his ...

Stock analysts at StockNews.com began coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Get Free Report) in a research report issued to clients and investors on Saturday. The firm set a “sell ...

Omaha Housing Authority tenants filed a class action complaint alleging that residents have been the victims of a "sustained, intense, and insidious infestation of bed bugs" for several years, ...

A novel topical gel, HT-001, has shown potential as a treatment for cutaneous side effects from epidermal growth factor ...